New study predicts how SARS-CoV-2 evades vaccines
Models future SARS-CoV-2 mutations and forecasts their ability to evade immune defenses developed by vaccines and antibody-based treatments
Models future SARS-CoV-2 mutations and forecasts their ability to evade immune defenses developed by vaccines and antibody-based treatments
Company testing three existing COVID-19 vaccine booster candidates against the Omicron variant
Data are now available from all enrolled participants
A true walk away ‘sample to answer’ molecular diagnostic system designed for high throughput testing, offering a time-efficient and seamless workflow for clinical laboratories
Novel contrast agent is being developed to address the medical need of patients with poor kidney function
Study will assess the immune response of the vaccine which is based on a genetically modified version of a common cold virus
New preclinical data further supports ability of CM-101 to break the vicious cycle of inflammation and fibrosis in primary sclerosing cholangitis
First clinical trial injecting naked mRNA directly into the heart of patients undergoing elective coronary artery bypass surgery
Discover insights on topics from lab automation and drug development to clinical LC-MS/MS and point-of-care testing
The first patients have been enrolled in this trial to help treatment for Amyotrophic Lateral Sclerosis (ALS)
A flow cytometry technician shares how live high-speed image capture increases the range of information obtained from limited sample materials
Ziath announces the latest version of its 2D rack decoding web browser software, DP5 Network
The partnership will incorporate SCIENION’s CL2 sciREADER system into the PictArray SARS-CoV-2 Serology Test which will shortly begin clinical trials for FDA EUA market clearance
Explore the importance of the European Pharmacopoeia to pharma manufacturers worldwide, with exclusive insights into the recently released version
Today’s activities are part of ongoing implementation of new authorities for certain over-the-counter drugs
ELRIG’s EDI Guiding Principles promote inclusivity and collaboration in the drug discovery community
Chemomab’s CM-101 is a first-in-class, CCL24-neutralizing monoclonal antibody expected to enter a Phase 2 clinical trial in SSc patients early next year
The rates of self-harm could be rising more quickly in children and adolescents from ethnic minority groups than in those from white groups, according to a study led by University of Manchester researchers
These findings are the first evidence that a pre-emptive intervention during infancy could lead to a child falling below the threshold for a clinical diagnosis of autism
First dose delivered to patients in a multi-center U.S. clinical trial to evaluate novel gamma-delta T cell cancer therapy
Using Cytel’s expertise, the TOGETHER Trial simultaneously tests multiple repurposed therapies
Researchers announce the results of a study into thrombocytopenia and thromboembolic events following Covid-19 vaccination
A certain type of smile can help to restore trust in relationships after someone has been uncooperative or untrustworthy, according to new research by Queen’s University Belfast
Adults who have received a double vaccination are 47% less likely to have long COVID
Obtaining two vaccine doses remains the most effective way to ensure protection against the COVID-19 Delta variant